Senators Push Drugmakers on Low-cost Insulin

Two U.S. senators are demanding that the nation’s three largest insulin makers, Novo Nordisk, Eli Lilly, and Sanofi, provide details by Sept. 15 of their programs to help Americans get their insulin for $35 a month or less. Democratic Senators Maggie Hassan and Tina Smith…[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.